{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:55:00Z","timestamp":1788566100425,"version":"build-2803163510"},"reference-count":54,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2020-RW330-002"],"award-info":[{"award-number":["2020-RW330-002"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease Markers"],"published-print":{"date-parts":[[2022,2,23]]},"abstract":"<jats:p>\n                    Purpose. This study is aimed at investigating the association between the metabolic score for insulin resistance (METS-IR) index and nonalcoholic fatty liver disease (NAFLD) in the nonobese population and its predictive value. Methods. 10730 nonobese subjects were selected from longitudinal cohort research conducted from January 2010 to December 2014. Cox proportional hazards models were employed to assess the relationship between METS-IR and new-onset NAFLD. Generalized additive models were used to identify nonlinear relationships. In addition, we performed subgroup analyses and interaction tests. The time-dependent receiver operating curve (ROC) and area under the ROC (AUC) were utilized to measure the discriminatory ability of METS-IR for new-onset NAFLD. Beyond clinical risk factors, the incremental predictive value of METS-IR was appraised using integrated discrimination improvement (IDI), C-index, and net reclassification index (NRI). Results. Over a median period of 804.50 days of follow-up, 1859 (17.33%) participants had a new onset of NAFLD. After adjusting for confounders, the HR for new-onset NAFLD in the Q4 group was 6.40 compared with the Q1 group. When METS-IR was considered a continuous variable, the risk of NAFLD increased by 34% for every 1 SD increase in METS-IR. The smoothing curve shows the dose-response relationship between METS-IR and the presence of new-onset NAFLD. Using a two-piecewise linear regression model, we derived a METS-IR inflection point of 36. HRs were 1.31 on the left side of the inflection point and 1.04 on the right side of the inflection point (log-likelihood ratio test,\n                    <jats:inline-formula>\n                      <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>P<\/a:mi>\n                        <a:mo>&lt;<\/a:mo>\n                        <a:mn>0.001<\/a:mn>\n                      <\/a:math>\n                    <\/jats:inline-formula>\n                    ). Subgroup analyses and interaction tests revealed an interaction between gender and SBP in the association between METS-IR and new-onset NAFLD. In the subgroup analysis of gender and SBP, we observed a higher risk of new-onset NAFLD in men and in those with abnormal SBP levels. We evaluated the ability of METS-IR to identify new-onset NAFLD at different time points. The AUCs at 1, 2, 3, and 4 years were 0.784, 0.756, 0.758, and 0.752, respectively, which represent good discrimination of new-onset NAFLD. The addition of METS-IR greatly improved the reclassification and differentiation of clinical risk factors, with an NRI of 0.276 and an IDI of 0.068. In addition, the addition of METS-IR increased the C-index from 0.719 to 0.771. Conclusion. In a nonobese Chinese population, elevated METS-IR was independently associated with an enhanced risk of NAFLD development and a dose-response relationship existed. In addition, METS-IR might be a reliable indicator for screening individuals at risk for early NAFLD, especially in nonobese populations.\n                  <\/jats:p>","DOI":"10.1155\/2022\/4930355","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T17:35:06Z","timestamp":1645637706000},"page":"1-10","source":"Crossref","is-referenced-by-count":41,"title":["Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3172-1540","authenticated-orcid":true,"given":"Xintian","family":"Cai","sequence":"first","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"},{"name":"Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[{"name":"Research and Education Center of Xinjiang Uygur Autonomous Region People\u2019s Hospital, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Hu","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wen","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"},{"name":"Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"},{"name":"Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Wang","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hong","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunfan","family":"Yang","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guzailinuer","family":"Tuerxun","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-8566","authenticated-orcid":true,"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[{"name":"Hypertension Center of People\u2019s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Medical Research Center for Hypertension Diseases, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"issue":"3","key":"1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Z. M. Younossi","year":"2019","journal-title":"Journal of Hepatology"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S302934"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S229691"},{"key":"4","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/hep.28584","article-title":"Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"A. Lonardo","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"J. Li","year":"2019","journal-title":"The lancet. Gastroenterology & hepatology"},{"key":"6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Z. M. Younossi","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12944-021-01457-1","article-title":"LDL\/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study","volume":"20","author":"Y. Zou","year":"2021","journal-title":"Lipids in Health and Disease"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9047324"},{"key":"9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"S. A. Polyzos","year":"2019","journal-title":"Metabolism, Clinical and Experimental"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1844-5"},{"key":"11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","article-title":"Nonobese fatty liver disease","volume":"15","author":"D. Kim","year":"2017","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.08.008"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8852198"},{"key":"14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Q. Ye","year":"2020","journal-title":"The lancet. Gastroenterology & hepatology"},{"key":"15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study","volume":"2","author":"H. Hagstr\u00f6m","year":"2018","journal-title":"Hepatology communications"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2018.01.007"},{"key":"17","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/ajg.2012.314","article-title":"Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults","volume":"107","author":"Y. M. Kwon","year":"2012","journal-title":"The American Journal of Gastroenterology"},{"key":"18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"C. Rosso","year":"2019","journal-title":"Journal of Hepatology"},{"key":"19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"R. S. Khan","year":"2019","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S343491"},{"key":"21","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1515\/cclm-2021-0643","article-title":"Distribution of HOMA-IR in a population-based cohort and proposal for reference intervals","volume":"59","author":"B. Matli","year":"2021","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2947067"},{"key":"23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/jch.13591","article-title":"METS-IR, a novel simple insulin resistance indexes, is associated with hypertension in normal-weight Chinese adults","volume":"21","author":"X. Z. Liu","year":"2019","journal-title":"Journal of Clinical Hypertension (Greenwich, Conn.)"},{"key":"24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-17-0883","article-title":"METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes","volume":"178","author":"O. Y. Bello-Chavolla","year":"2018","journal-title":"European Journal of Endocrinology"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080742"},{"key":"26","article-title":"Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study","volume":"6, article e013781","author":"D. Q. Sun","year":"2016","journal-title":"BMJ Open"},{"key":"27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","article-title":"Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases","volume":"9","author":"M. D. Zeng","year":"2008","journal-title":"Journal of Digestive Diseases"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S319759"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S336990"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9953858"},{"key":"31","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/ajg.2013.104","article-title":"Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study","volume":"108","author":"C. Xu","year":"2013","journal-title":"The American Journal of Gastroenterology"},{"key":"32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1381\/0960892053576820","article-title":"Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients","volume":"15","author":"J. P. Ong","year":"2005","journal-title":"Obesity Surgery"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70506-8"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S317081"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S300450"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S268916"},{"key":"37","article-title":"An overview of lipid metabolism and nonalcoholic fatty liver disease","volume":"2020","author":"K. Pei","year":"2020","journal-title":"BioMed Research International"},{"key":"38","article-title":"Nonalcoholic fatty liver disease-associated liver fibrosis is linked with the severity of coronary artery disease mediated by systemic inflammation","volume":"2021","author":"L. Z. Chen","year":"2021","journal-title":"Disease Markers"},{"key":"39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/hep4.1519","article-title":"Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis","volume":"4","author":"S. Young","year":"2020","journal-title":"Hepatology communications"},{"key":"40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ajg.2011.400","article-title":"Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults","volume":"107","author":"D. H. Sinn","year":"2012","journal-title":"The American Journal of Gastroenterology"},{"key":"41","first-page":"126","article-title":"Elevated triglycerides\/HDL-cholesterol ratio associated with insulin resistance","volume":"79","author":"A. Gonz\u00e1lez-Ch\u00e1vez","year":"2011","journal-title":"Cirugia y Cirujanos"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00033.2003"},{"key":"43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"G. F. Lewis","year":"2002","journal-title":"Endocrine Reviews"},{"key":"44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12944-019-1104-6","article-title":"Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research","volume":"18","author":"Z. Chen","year":"2019","journal-title":"Lipids in Health and Disease"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-018-0420-4"},{"key":"46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","article-title":"Clinical and metabolic characterization of lean Caucasian subjects with non-alcoholic fatty liver","volume":"112","author":"A. Feldman","year":"2017","journal-title":"The American Journal of Gastroenterology"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.235"},{"key":"48","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"S. Romeo","year":"2008","journal-title":"Nature Genetics"},{"key":"49","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"M. Mota","year":"2016","journal-title":"Metabolism, Clinical and Experimental"},{"key":"50","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"E. Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"51","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"L. Camont","year":"2011","journal-title":"Trends in Molecular Medicine"},{"key":"52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diabetes.52.2.453","article-title":"Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance","volume":"52","author":"W. T. Garvey","year":"2003","journal-title":"Diabetes"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10060395"},{"key":"54","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"S. Dasarathy","year":"2009","journal-title":"Journal of Hepatology"}],"container-title":["Disease Markers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2022\/4930355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2022\/4930355.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2022\/4930355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T19:23:44Z","timestamp":1700249024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/dm\/2022\/4930355\/"}},"subtitle":[],"editor":[{"given":"Faryal M.ehwish","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":54,"alternative-id":["4930355","4930355"],"URL":"https:\/\/doi.org\/10.1155\/2022\/4930355","relation":{},"ISSN":["1875-8630","0278-0240"],"issn-type":[{"value":"1875-8630","type":"electronic"},{"value":"0278-0240","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,23]]}}}